These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27381091)

  • 1. Challenges raised by cross-border testing of rare diseases in the European union.
    Pohjola P; Hedley V; Bushby K; Kääriäinen H
    Eur J Hum Genet; 2016 Nov; 24(11):1547-1552. PubMed ID: 27381091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dream vs. reality: seven case-studies on the desirability and feasibility of cross-border hospital collaboration in Europe.
    Glinos IA; Baeten R
    Soc Sci Med; 2014 Sep; 117():18-24. PubMed ID: 25025866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cross-border cooperation in Europe: what are Euregios?].
    Wolf U; Hollederer A; Brand H
    Gesundheitswesen; 2006 Nov; 68(11):667-73. PubMed ID: 17199199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' Rights in Cross-border Healthcare (Directive 2011/24/EU) and How It Applies to Turkey as a Negotiating Candidate Country.
    Ekmekci PE
    Eur J Health Law; 2017; 24(4):432-444. PubMed ID: 29203967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European union policy in the field of rare diseases.
    Montserrat Moliner A; Waligóra J
    Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating a European Union framework for actions in the field of rare diseases.
    Moliner AM
    Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interoperability Architecture for a Paediatric Oncology European Reference Network.
    Nitzlnader M; Canete Nieto A; Ribelles AJ; Brunmair B; Ladenstein R; Schreier G
    Stud Health Technol Inform; 2016; 223():39-45. PubMed ID: 27139383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating efficiency of Directive 2011/24/EU cross-border healthcare in member states.
    Ibrahim MD; Hocaoglu MB; Numan B; Daneshvar S
    J Comp Eff Res; 2018 Aug; 7(8):827-834. PubMed ID: 29770704
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of exchange of forensic DNA data in the European Union through the Prüm system.
    Santos F; Machado H
    Sci Justice; 2017 Jul; 57(4):307-313. PubMed ID: 28606337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-border healthcare directive: Assessing stakeholders' perspectives in Poland and Portugal.
    Helena R
    Health Policy; 2016 Apr; 120(4):369-76. PubMed ID: 26948704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross border access to healthcare services within the European Union.
    Sellars C
    World Hosp Health Serv; 2006; 42(1):23-5. PubMed ID: 16669372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Union Policy in the Field of Rare Diseases.
    Moliner AM; Waligora J
    Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immigration to Spain: implications for a unified European Union immigration policy.
    Huntoon L
    Int Migr Rev; 1998; 32(2):423-50. PubMed ID: 12293596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cross-border healthcare in European Union and Czech Republic].
    Barták M; Rogalewicz V; Jílková J; Jeřábková S
    Cas Lek Cesk; 2016; 155(5):247-253. PubMed ID: 27696889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who wants to cross borders in the EU for healthcare? An analysis of the Eurobarometer data in 2007 and 2014.
    Peralta-Santos A; Perelman J
    Eur J Public Health; 2018 Oct; 28(5):879-884. PubMed ID: 29697799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prüm Decisions as an Aspirational regime: Reviewing a Decade of Cross-Border Exchange and Comparison of Forensic DNA Data.
    Toom V; Granja R; Ludwig A
    Forensic Sci Int Genet; 2019 Jul; 41():50-57. PubMed ID: 30959458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cigarette price differences across the entire European Union on cross-border purchase of tobacco products among adult cigarette smokers.
    Agaku IT; Blecher E; Filippidis FT; Omaduvie UT; Vozikis A; Vardavas CI
    Tob Control; 2016 May; 25(3):333-40. PubMed ID: 25661415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating safe and successful cross-border healthcare in the European Union.
    Verra SE; Kroeze R; Ruggeri K
    Health Policy; 2016 Jun; 120(6):718-27. PubMed ID: 27142178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European Reference Networks : Consequences for healthcare in Germany].
    Graessner H; Schäfer F; Scarpa M; Wagner TOF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.